Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
551 - We have a patient survey conducted by a patient association looking at reasons for stopping therapy. Can we use this information in an unbranded APS to highlight the most common reasons for stopping therapy?
-
For the use described in your question, the surveys would either need to be published in a peer reviewed journal, or it would need to be designed, conducted & analyzed without sponsor’s influence (s5.10.2). The messaging would be limited to aspects which are non-clinical (so as not to require a clinical trial as evidentiary support) and you’ll need to remove messaging deemed to be disparaging to a product or product class/category. CAVEAT: This is a very general answer to a general question. There are MANY factors which could impact whether a survey is acceptable as evidentiary support. In my experience, things have gone more smoothly when clients first submitted the survey (or at least a thorough description) in a written opinion request (see our fee schedule) along with the types of messages they wished to convey. Sometimes the issue is the reference, but often the issue is the underlying message.